Aarhus University Seal

Researchers uncover molecular link between immune protein and inflammation

Researchers at the Department of Molecular Biology and Genetics, together with international collaborators, have uncovered how the immune protein STING activates a key part of the cellular inflammatory response. The findings provide new insight into immune signalling and could, in the longer term, contribute to research into more targeted treatments for harmful inflammation.

A swollen and painful finger is an example of inflammation. The response is part of the body’s defence system and helps fight infections and repair damaged tissue.

However, inflammation needs to be carefully regulated. If the response becomes too strong or persists for too long, it can damage the body’s own tissues. In the lungs, a severe inflammatory response can cause fluid to accumulate in the lung tissue and impair breathing, which can be dangerous for the patient.

STING passes on the alarm signal

One of the proteins involved in activating the immune system is STING – short for stimulator of interferon genes. The protein is part of the cell’s alarm system and receives signals from sensors that detect foreign or misplaced DNA.

When STING is activated, it triggers signalling pathways that contribute to both antiviral defence and inflammation. One of these is the NF-κB signalling pathway, which can activate genes encoding inflammatory signalling molecules. However, exactly how STING activates this pathway has remained less clear.

A molecular bridge connects the signals

This connection is what Anna Hvarregaard Christensen and Aneta J. Jurkiewicz from Rune Hartmann’s research group at MBG have investigated together with their colleagues. They are co-first authors of the study, which has been published in Science Immunology.

Through a series of experiments, the researchers investigated how STING is connected to the IKK complex, which plays an important role in the activation of NF-κB.

“What we have discovered is that the connection between STING and the NF-κB signalling pathway is a molecule called linear ubiquitin,” explains Professor Rune Hartmann.

Ubiquitin is a small protein that can be linked together in chains. The researchers showed that, when activated, STING recruited an important signalling complex known as the IKK complex. They then demonstrated that linear ubiquitin chains are necessary for the IKK complex to associate with activated STING in human cells. According to the researchers’ model, these chains act as a molecular bridge.

At the same time, the IKK complex must cooperate with other signalling enzymes recruited by STING in order to fully activate NF-κB signalling.

A possible route towards more targeted treatment

This connection could be of interest in the longer term if researchers want to reduce harmful inflammation more precisely. Both the IKK complex and the ubiquitin system are involved in many essential processes in the body, making it potentially problematic to block them broadly.

Instead, a possible long-term goal would be to disrupt the specific connection to STING, thereby limiting the inflammatory response while preserving the necessary antiviral defence.

“That is why we need to understand the molecular details,” says Rune Hartmann.

Basic research with a long-term perspective

Rune Hartmann points out that a better understanding of STING-driven inflammation could be relevant to both infections and certain inflammatory diseases. He mentions, among others, some forms of arthritis and psoriasis as possible areas of relevance.

“As I see it, this could potentially be useful in several contexts, because many diseases are driven by inflammation,” he says.

The study maps a fundamental mechanism underlying STING function, and through a strong collaboration with Jean-Luc Imler and his research group in Strasbourg, the researchers have shown that the connection between STING and the IKK complex is evolutionarily conserved across animals.

However, there is still a long way to go before this could potentially lead to a treatment. Among other things, the researchers still need to determine how STING initiates the formation of the linear ubiquitin chains and exactly which protein the chains are attached to.